Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the closing exchange rate reported in The Wall Street Journal for the last Business Day of the applicable calendar quarter.
Appears in 3 contracts
Sources: License and Collaboration Agreement (Savara Inc), License Agreement (Derma Sciences, Inc.), License and Collaboration Agreement (Aradigm Corp)
Foreign Exchange. The rate of exchange to be used in computing Net Sales and the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies United States dollars due Exelixis shall be made at the closing rate of exchange rate reported in The Wall Street Journal for quoted as of the end of the day on the last Business Day business day of the applicable royalty period (calendar quarterquarter period) in the Wall Street Journal.
Appears in 3 contracts
Sources: Research Collaboration and Technology Transfer Agreement (Exelixis Inc), Research Collaboration and Technology Transfer Agreement (Exelixis Inc), Research Collaboration and Technology Transfer Agreement (Exelixis Inc)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars United States dollars of Net Sales invoiced in other currencies shall be made at the closing period-end rate of exchange rate reported in The Wall Street Journal for quoted on the last Business Day business day of the applicable calendar quarterquarter by Citibank in New York City or, to the extent mutually agreed by the Parties, any other widely accepted source of published exchange rates.
Appears in 2 contracts
Sources: Collaboration, Supply, Marketing and Distribution Agreement (Galectin Therapeutics Inc), Collaboration, Supply, Marketing and Distribution Agreement (Galectin Therapeutics Inc)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the average of the closing exchange rate rates reported in The Wall Street Journal for the last Business Day of over the applicable calendar quarterreporting period.
Appears in 2 contracts
Sources: License and Collaboration Agreement (Intra-Cellular Therapies, Inc.), License and Collaboration Agreement (Intra-Cellular Therapies, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the closing exchange rate rates reported in The Wall Street Journal for (U.S., Western Edition) on the last Business Day business day of the applicable calendar quarterCalendar Quarter for which the payment is made.
Appears in 2 contracts
Sources: License Agreement (Catalyst Pharmaceutical Partners, Inc.), License Agreement (Catalyst Pharmaceutical Partners, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the average of the daily closing exchange rate rates reported in The Wall Street Journal (U.S., Western Edition) over the applicable reporting period for the last Business Day of the applicable calendar quarterpayment due.
Appears in 2 contracts
Sources: Development, Commercialization Collaboration and License Agreement (Kalobios Pharmaceuticals Inc), Development, Commercialization Collaboration and License Agreement (Kalobios Pharmaceuticals Inc)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars United States dollars of Net Sales invoiced and Development Costs, Pre-Launch Commercialization Costs, and Allowable Expenses incurred in other currencies shall be made at the closing period-end rate of exchange rate reported in The Wall Street Journal for quoted on the last Business Day business day of the applicable calendar quarterquarter by Citibank in New York City or, to the extent mutually agreed by the Parties, any other widely accepted source of published exchange rates.
Appears in 1 contract
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the average of the daily closing exchange rate rates reported in The Wall Street Journal (U.S., Western Edition) over the applicable reporting period for the last Business Day of the applicable calendar quarter.payment due. [***] CONFIDENTIAL PORTIONS OF THIS DOCUMENT REDACTED AND FILED SEPARATELY WITH THE COMMISSION
Appears in 1 contract
Sources: Development, Commercialization Collaboration and License Agreement (Kalobios Pharmaceuticals Inc)